You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Claims for Patent: 11,896,567

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 11,896,567

Title:	Combination composition
Abstract:	An intravenous composition for providing relief for pain and/or inflammation, the composition having ibuprofen and paracetamol in combination for delivering to a human at each dose:a) approximately 125 mg to approximately 175 mg ibuprofen in combination with approximately 475 mg to approximately 525 mg paracetamol; orb) approximately 275 mg to approximately 325 mg ibuprofen in combination with approximately 975 mg to approximately 1,025 mg paracetamol.
Inventor(s):	Hartley C. Atkinson
Assignee:	AFT Pharmaceuticals Ltd
Application Number:	US17/943,708
Patent Claims:	1. A method of treating pain by intravenously administering to a human, 100 ml of an aqueous solution comprising: a) 150 mg ibuprofen in combination with 500 mg paracetamol; or b) 300 mg ibuprofen in combination with 1000 mg paracetamol. 2. The method according to claim 1, wherein the aqueous solution is administered on a 6 hourly basis. 3. The method of claim 1, wherein the aqueous solution comprises 150 mg ibuprofen in combination with 500 mg paracetamol. 4. The method of claim 1, wherein the aqueous solution comprises 300 mg ibuprofen in combination with 1000 mg paracetamol. 5. The method of claim 2, wherein the aqueous solution comprises 150 mg ibuprofen in combination with 500 mg paracetamol. 6. The method of claim 2, wherein the aqueous solution comprises 300 mg ibuprofen in combination with 1000 mg paracetamol. 7. A method of treating pain by intravenously administering to a human, an aqueous solution comprising: a) 150 mg ibuprofen in combination with 500 mg paracetamol; or b) 300 mg ibuprofen in combination with 1000 mg paracetamol, wherein the administration takes place over 15 minutes. 8. The method according to claim 7, wherein the aqueous solution is administered on a 6 hourly basis. 9. The method of claim 7, wherein the aqueous solution comprises 150 mg ibuprofen in combination with 500 mg paracetamol. 10. The method of claim 7, wherein the aqueous solution comprises 300 mg ibuprofen in combination with 1000 mg paracetamol. 11. The method of claim 8, wherein the aqueous solution comprises 150 mg ibuprofen in combination with 500 mg paracetamol. 12. The method of claim 8, wherein the aqueous solution comprises 300 mg ibuprofen in combination with 1000 mg paracetamol. 13. A method of treating pain by intravenously administering to a human, 100 ml of an aqueous solution comprising: a) 150 mg ibuprofen in combination with 500 mg paracetamol; or b) 300 mg ibuprofen in combination with 1000 mg paracetamol, wherein the administration takes place over 15 minutes. 14. The method according to claim 13, wherein the aqueous solution is administered on a 6 hourly basis. 15. The method of claim 13, wherein the aqueous solution comprises 150 mg ibuprofen in combination with 500 mg paracetamol. 16. The method of claim 13, wherein the aqueous solution comprises 300 mg ibuprofen in combination with 1000 mg paracetamol. 17. The method of claim 14, wherein the aqueous solution comprises 150 mg ibuprofen in combination with 500 mg paracetamol. 18. The method of claim 14, wherein the aqueous solution comprises 300 mg ibuprofen in combination with 1000 mg paracetamol.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.